human | Q5 |
P496 | ORCID iD | 0000-0002-7334-7924 |
P69 | educated at | Yale University | Q49112 |
Harvard Medical School | Q49121 | ||
P108 | employer | Brigham and Women's Hospital | Q2900977 |
P735 | given name | Carolyn | Q18091370 |
Carolyn | Q18091370 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | female | Q6581072 |
Q37504006 | A clinical approach to inherited hypertrophy: the use of family history in diagnosis, risk assessment, and management. |
Q36420143 | A clinician's guide to tissue Doppler imaging. |
Q36511747 | A contemporary approach to hypertrophic cardiomyopathy. |
Q24602132 | A novel custom resequencing array for dilated cardiomyopathy |
Q46506724 | Advanced assessment of cardiac morphology and prediction of gene carriage by CMR in hypertrophic cardiomyopathy - the HCMNet/UCL collaboration. |
Q61897195 | Assessment of Diastolic Function With Doppler Tissue Imaging to Predict Genotype in Preclinical Hypertrophic Cardiomyopathy |
Q34030488 | Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, disease severity, and alpha-galactosidase A activity |
Q57841015 | Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations |
Q115579338 | Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy |
Q33930898 | Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy |
Q37683177 | Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy. |
Q115579471 | Discordant clinical features of identical hypertrophic cardiomyopathy twins |
Q30480164 | Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy |
Q48604561 | Effect of radiofrequency catheter ablation of ventricular tachycardia on left ventricular function in patients with prior myocardial infarction |
Q37631139 | Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy. |
Q35549595 | Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy. |
Q34399188 | Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy |
Q58087435 | Faster cross-bridge detachment and increased tension cost in human hypertrophic cardiomyopathy with the R403Q MYH7 mutation |
Q50281368 | Fibrotic content of LV myocardium quantified by CMR characterizes left atrial sizes and total left atrial emptying function incremental to LV functional parameters and LV myocardial mass index in patients with hypertrophic cardiomyopathy |
Q28280136 | Gene mutations in apical hypertrophic cardiomyopathy |
Q58087460 | Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations |
Q36882310 | Genetic testing for dilated cardiomyopathy in clinical practice |
Q37160655 | Genetic testing for inherited heart disease |
Q61897173 | Genetic testing in cardiac disease: from bench to bedside |
Q30418104 | Genetics and cardiovascular disease: a policy statement from the American Heart Association. |
Q34999606 | Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy |
Q61897170 | Heart Failure and Genomics |
Q94995169 | Hypertrophic Cardiomyopathy Overview |
Q61897156 | Hypertrophic cardiomyopathy |
Q35893667 | Hypertrophic cardiomyopathy in 2012 |
Q37766183 | Hypertrophic cardiomyopathy: preclinical and early phenotype. |
Q61897197 | Linkage of a familial platelet disorder with a propensity to develop myeloid malignancies to human chromosome 21q22.1-22.2 |
Q43442575 | Multimodality non-invasive imaging of a coronary cameral fistula. |
Q37696227 | Muscle dysfunction in hypertrophic cardiomyopathy: what is needed to move to translation? |
Q34629550 | Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy |
Q41836826 | New Paradigms in Hypertrophic Cardiomyopathy: Insights from Genetics. |
Q61897174 | Novel Locus for an Inherited Cardiomyopathy Maps to Chromosome 7 |
Q28287468 | Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations |
Q51547073 | Postinfarction ventricular septal defect with pseudoaneurysm repair after failed percutaneous closure. |
Q34543914 | Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy |
Q61897151 | Profound Left Ventricular Remodeling Associated With LAMP2 Cardiomyopathy |
Q41543943 | Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. |
Q91757740 | Screening children at risk for hypertrophic cardiomyopathy: balancing benefits and harms |
Q41511752 | Short communication: the cardiac myosin binding protein C Arg502Trp mutation: a common cause of hypertrophic cardiomyopathy |
Q96130312 | Study Design and Rationale of EXPLORER-HCM: Evaluation of Mavacamten in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy |
Q36823735 | Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy |
Q55403546 | T1 measurements identify extracellular volume expansion in a genotyped hypertrophic cardiomyopathy population with and without left ventricular hypertrophy. |
Q37160724 | T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy |
Q41626761 | The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial |
Q30585056 | The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine |
Q35845452 | The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance |
Q34254460 | Truncations of titin causing dilated cardiomyopathy. |
Q53368381 | [Clinical spectrum of preclinical hypertrophic cardiomyopathy: characterizing carriers of sarcomere gene mutation]. |
Search more.